MedTrace Logo

Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma

NCT00003151 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2012-07-02

No results posted yet for this study

Summary

RATIONALE: Antibiotics may stop the growth of Helicobacter pylori which may be associated with gastric lymphoma.

PURPOSE: Phase II trial to study the effectiveness of antibiotic therapy in treating patients with low grade gastric lymphoma that has not been previously treated.

Conditions

Interventions

DIETARY_SUPPLEMENT

bismuth subcitrate

DRUG

amoxicillin

DRUG

clarithromycin

DRUG

metronidazole hydrochloride

DRUG

omeprazole

DRUG

tetracycline hydrochloride

Sponsors & Collaborators

  • University of Glasgow

    collaborator OTHER

  • European Organisation for Research and Treatment of Cancer - EORTC

    lead NETWORK

Principal Investigators

  • Patrice P. Carde, MD · Gustave Roussy, Cancer Campus, Grand Paris

  • John W. Sweetenham, MD · University of Colorado, Denver

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-09-30
Primary Completion
1998-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00003151 on ClinicalTrials.gov